Ever wonder what happens when your go-to pharmacy brands go global? India’s Aurobindo Pharma is eyeing a massive $5.5 billion buyout of Zentiva, a big name in affordable meds across Europe. If this deal goes through, you might see more wallet-friendly generics on your pharmacy shelf soon. But for now, investors are jittery—Aurobindo’s stock dipped after the news broke. Stay tuned for more affordable options (and drama) in your medicine cabinet! #Business #EntrepreneurshipStartup #PharmaNews